Drew Moghanaki: The embargo has been lifted on the results for the LU-005 trial for LS-SCLC

Drew Moghanaki shared a post on X:

“The embargo has been lifted on the results for the LU-005 phase III randomized clinical trial for LS-SCLC.”

Source: Drew Moghanaki/X

Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.

He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).